| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/16/2023 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 15k | $1.23 | $18.4k | | 08/16/2023 |
| 06/08/2023 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 40k | $1.50 | $60k | | 06/08/2023 |
| 05/25/2023 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 05/25/2023 |
| 02/25/2023 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 02/25/2023 |
| 11/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 11/25/2022 |
| 09/30/2022 | Indaptus Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 81k | $2.16 | $175k | | 09/30/2022 |
| 08/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 08/25/2022 |
| 06/09/2022 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 40k | $3.24 | $129.6k | | 06/09/2022 |
| 02/25/2022 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 9k | $0.00 | $0 | | 02/25/2022 |
| 02/15/2022 | CONTRAFECT Corp | CFRX | Grant | Options (Right to Buy) | 500k | $3.33 | $1.7M | | 02/15/2022 |
| 11/25/2021 | Viracta Therapeutics, Inc. | VIRX | Exercise | Restricted Stock Units | 18.1k | $0.00 | $0 | | 11/25/2021 |
| 08/04/2021 | Indaptus Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 41k | $8.87 | $363.7k | | 08/04/2021 |
| 04/08/2021 | CONTRAFECT Corp | CFRX | Grant | Options (Right to Buy) | 254k | $4.31 | $1.1M | | 04/08/2021 |
| 03/26/2021 | Viracta Therapeutics, Inc. | VIRX | Grant | Stock Option (Right to Buy) | 135k | $8.74 | $1.2M | | 03/26/2021 |
| 07/15/2020 | Intec Pharma Ltd. | NTEC | Grant | Stock Option (right to buy) | 40k | $0.31 | $12.3k | | 07/15/2020 |
| 06/28/2019 | Intec Pharma Ltd. | NTEC | Grant | Stock Option (right to buy) | 20k | $4.86 | $97.2k | | 06/28/2019 |
| 06/13/2019 | Seres Therapeutics, Inc. | MCRB | Grant | Stock Option (right to buy) | 15k | $2.83 | $42.4k | | 06/13/2019 |
| 09/07/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 1.8k | $9.00 | $16.3k | | 09/07/2018 |
| 09/06/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 3k | $9.04 | $27.2k | | 09/05/2018 |
| 09/05/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 9.5k | $9.12 | $86.7k | | 09/05/2018 |
| 07/20/2018 | Rubius Therapeutics, Inc. | RUBY | Purchase | Common Stock | 100 | $23.00 | $2.3k | | 07/20/2018 |
| 07/17/2018 | Rubius Therapeutics, Inc. | RUBY | Grant | Stock Option (Right to Buy) | 25k | $23.00 | $575k | | 07/17/2018 |
| 07/11/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 1k | $9.01 | $9.1k | | 07/11/2018 |
| 07/11/2018 | Seres Therapeutics, Inc. | MCRB | Exercise | STOCK OPTION (RIGHT TO BUY) | 1k | $0.71 | $717.1 | | 07/11/2018 |
| 07/10/2018 | Seres Therapeutics, Inc. | MCRB | Exercise | STOCK OPTION (RIGHT TO BUY) | 6k | $0.71 | $4.3k | | 07/06/2018 |
| 07/10/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 6k | $9.05 | $54.2k | | 07/06/2018 |
| 07/09/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 11k | $9.14 | $100.4k | | 07/06/2018 |
| 07/09/2018 | Seres Therapeutics, Inc. | MCRB | Exercise | STOCK OPTION (RIGHT TO BUY) | 11k | $0.71 | $7.8k | | 07/06/2018 |
| 07/06/2018 | Seres Therapeutics, Inc. | MCRB | Exercise | STOCK OPTION (RIGHT TO BUY) | 15.4k | $0.71 | $10.9k | | 07/06/2018 |
| 07/06/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 15.4k | $9.14 | $140.5k | | 07/06/2018 |
| 06/29/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 4.5k | $9.10 | $40.9k | | 06/28/2018 |
| 06/29/2018 | Seres Therapeutics, Inc. | MCRB | Exercise | STOCK OPTION (RIGHT TO BUY) | 4.5k | $0.71 | $3.2k | | 06/28/2018 |
| 06/28/2018 | Seres Therapeutics, Inc. | MCRB | Exercise | STOCK OPTION (RIGHT TO BUY) | 21.6k | $0.71 | $15.3k | | 06/28/2018 |
| 06/28/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 21.6k | $9.15 | $197.4k | | 06/28/2018 |
| 06/27/2018 | Seres Therapeutics, Inc. | MCRB | Sale | Common Stock | 17k | $9.03 | $153.4k | | 06/25/2018 |
|